Pages that link to "Q44354566"
Jump to navigation
Jump to search
The following pages link to Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy (Q44354566):
Displaying 38 items.
- Targets for therapy in sarcomeric cardiomyopathies (Q27027023) (← links)
- Research priorities in sarcomeric cardiomyopathies (Q27694507) (← links)
- Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus (Q28087567) (← links)
- Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes (Q28255887) (← links)
- Hypertrophic obstructive cardiomyopathy (Q33167969) (← links)
- Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations (Q34219487) (← links)
- Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. (Q36279078) (← links)
- Rapid large-scale purification of myofilament proteins using a cleavable His6-tag (Q36339414) (← links)
- Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (Q37014695) (← links)
- Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation? (Q37696227) (← links)
- Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases (Q37701056) (← links)
- From stem cells to cardiomyocytes: the role of forces in cardiac maturation, aging, and disease. (Q38235819) (← links)
- Structural implications of β-cardiac myosin heavy chain mutations in human disease (Q38240077) (← links)
- Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function (Q38826141) (← links)
- Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model. (Q40042653) (← links)
- ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study). (Q41815143) (← links)
- Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios. (Q42320941) (← links)
- Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy (Q42515078) (← links)
- Hypothesis and theory: mechanical instabilities and non-uniformities in hereditary sarcomere myopathies (Q42877248) (← links)
- Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy (Q47170506) (← links)
- Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals (Q48177445) (← links)
- Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice. (Q51128798) (← links)
- Burst-Like Transcription of Mutant and Wildtype MYH7-Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy. (Q52804423) (← links)
- Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review (Q57465354) (← links)
- Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels (Q57465786) (← links)
- Microtubule associated protein 4 phosphorylation leads to pathological cardiac remodeling in mice (Q57468418) (← links)
- Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation (Q58087435) (← links)
- Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology (Q61651710) (← links)
- A step towards understanding the molecular nature of human heart failure: advances using the Sydney Heart Bank collection (Q64068696) (← links)
- Five-year prognostic significance of global longitudinal strain in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes (Q64231161) (← links)
- Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle. (Q64971291) (← links)
- Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy. (Q64975647) (← links)
- CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy (Q88613563) (← links)
- The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM (Q90711478) (← links)
- Novel pathogenic variants in filamin C identified in pediatric restrictive cardiomyopathy (Q91802602) (← links)
- Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy (Q92027205) (← links)
- Direct Sarcomere Modulators Are Promising New Treatments for Cardiomyopathies (Q92441606) (← links)
- Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics (Q96343427) (← links)